TURNOVER (x1000 NOK)
NET PROFIT (x1000 NOK)
EMPLOYEES
Biobact AB
Closing information (x1000 NOK)
| Closing information | 2024/12 | 2023/12 | 2022/12 |
| Turnover |
0
|
0
|
237 |
| Financial expenses |
1
|
11
|
74 |
| Earnings before taxes |
61
|
-122
|
4,591 |
| EBITDA |
-153
|
-186
|
-1,361 |
| Total assets |
1,181
|
3,634
|
5,345 |
| Current assets |
891
|
2,217
|
5,345 |
| Current liabilities |
880
|
54
|
1,890 |
| Equity capital |
301
|
3,580
|
3,455 |
| - share capital |
103
|
101
|
95 |
| Employees (average) |
1
|
1
|
2 |
Financial ratios
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Solvency |
25.5%
|
98.5%
|
64.6% |
| Turnover per employee |
0
|
0
|
118 |
| Profit as a percentage of turnover | 1937.1% | ||
| Return on assets (ROA) |
5.2%
|
-3.1%
|
87.3% |
| Current ratio |
101.2%
|
4105.6%
|
282.8% |
| Return on equity (ROE) |
20.3%
|
-3.4%
|
132.9% |
| Change turnover |
0
|
-254
|
-972 |
| Change turnover % |
-100%
|
-80% | |
| Chg. No. of employees |
0
|
-1
|
-2 |
| Chg. No. of employees % |
0%
|
-50%
|
-50% |
Total value of public sale
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.